Gen-Probe (US) licenses patented tests to Becton Dickinson (US):
This article was originally published in Clinica
Gen-Probe (US) has granted Becton Dickinson (US) a non-exclusive worldwide right to its patented methods for detecting vaginosis and vaginitis. In exchange for the rights to patent nos 4,851,330 and 5,288,611, Becton will make an upfront payment of an undisclosed sum and pay a royalty on sales of the licensed products. Becton says it will also defend Gen-Probe's patents against further infringement. The patents are "in a disease category that Gen-Probe currently has no plans to enter", says president and CEO Henry Nordhoff.